Education
About Us
Working with TipRanks
Follow Us
Aethlon Medical Inc (AEMD)
NASDAQ:AEMD
Total Valuation
Aethlon Medical has a market cap or net worth of $3.44M. The enterprise value is -$586.88K.
Market Cap$3.44M
Enterprise Value-$586.88K
Share Statistics
Aethlon Medical has 761,211 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding761,211
Owned by Insiders15.94%
Owned by Institutions<0.01%
Financial Efficiency
Aethlon Medical’s return on equity (ROE) is -2.61 and return on invested capital (ROIC) is -161.80%.
Return on Equity (ROE)-2.61
Return on Assets (ROA)-1.82
Return on Invested Capital (ROIC)-161.80%
Return on Capital Employed (ROCE)-1.71
Revenue Per Employee0.00
Profits Per Employee-956.29K
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aethlon Medical is ―. Aethlon Medical’s PEG ratio is -0.00436.
PE Ratio―
PS Ratio0.00
PB Ratio0.87
Price to Fair Value0.87
Price to FCF-0.58
Price to Operating Cash Flow>-0.01
PEG Ratio-0.00436
Income Statement
In the last 12 months, Aethlon Medical had revenue of 0.00 and earned -13.39M in profits. Earnings per share was -85.80.
Revenue0.00
Gross Profit-339.56K
Operating Income-9.34M
Pretax Income-13.39M
Net Income-13.39M
EBITDA-13.04M
Earnings Per Share (EPS)-85.80
Cash Flow
In the last 12 months, operating cash flow was -3.38B and capital expenditures 0.00, giving a free cash flow of -3.38B billion.
Operating Cash Flow-3.38B
Free Cash Flow-3.38B
Free Cash Flow per Share-4.44K
Dividends & Yields
Aethlon Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.20
52-Week Price Change-86.83%
50-Day Moving Average6.43
200-Day Moving Average22.13
Relative Strength Index (RSI)31.34
Average Volume (3m)688.41K
Important Dates
Aethlon Medical upcoming earnings date is Feb 16, 2026, After Close (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateFeb 16, 2026
Ex-Dividend Date―
Financial Position
Aethlon Medical as a current ratio of 3.13, with Debt / Equity ratio of 16.76%
Current Ratio3.13
Quick Ratio3.13
Debt to Market Cap0.00
Net Debt to EBITDA0.37
Interest Coverage Ratio-924.06
Taxes
In the past 12 months, Aethlon Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Aethlon Medical EV to EBITDA ratio is 0.03, with an EV/FCF ratio of 0.05.
EV to Sales0.00
EV to EBITDA0.03
EV to Free Cash Flow0.05
EV to Operating Cash Flow0.05
Balance Sheet
Aethlon Medical has $5.85B in cash and marketable securities with $496.77M in debt, giving a net cash position of $5.36B billion.
Cash & Marketable Securities$5.85B
Total Debt$496.77M
Net Cash$5.36B
Net Cash Per Share$7.04K
Tangible Book Value Per Share$32.82
Margins
Gross margin is -797729.29%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-797729.29%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Aethlon Medical is $1.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$1.50
Price Target Upside-64.29% Downside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast78.72%